Predatory EU pacts
EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global
WTO gives India a clean chit
Apex trade regulator finds nothing amiss in India's intellectual property laws after exhaustive review
Unholy smoke!
Inclusion of intellectual property in bilateral investment agreements is injurious to the health of developing nations
Testing the CL route
Roche’s Herceptin will be a test case for government and generics industry as India readies to issue compulsory licences for life-saving drugs
Standing up to the US
India does not have to be apologetic about its patents law, which is fully compliant with WTO requirements on intellectual property protection
‘PESTICIDES’ IN DRUGS
Sharad Pawar’s provision for protecting test data in the Pesticides Bill could spill over into trade agreements and hit the drugs industry, too
Wooing the judges, openly
There is conflict of interest as US patent owners schedule meetings with Indian judiciary and patent regulators
Big step for biocultural rights
The Nagoya Protocol promotes community stewardship of genetic resources. India needs to foster this
Trail of a $500 m gene
How a rare African algae collected by a French academic turns into a commercial bonanza for an equity firm in Hong Kong. Are there any benefits …
The curious case of Ebola patents
The US government appears to have a cure and (almost) a vaccine for the deadly disease
Rising power of the knowledge commons
By ending ownership of ideas we can banish ignorance and change human history
The irrelevance of multilateralism
Rich countries gang up for a more strident intellectual property rights regime
Gene patent verdict is as good as it gets
The US Supreme Court’s verdict in the Myriad case keeps everyone happy
Jugaad of Indian innovation
Patting ourselves for our ability to arrive at makeshift solutions will not take us far
Indications of a geographic muddle
Are Geographical Indications safeguarding the interests of growers and artisans?
Drained royally by MNCs
Royalty payments to firms like Suzuki and Monsanto are sucking out huge sums from India
A nobel indictment of gene patenting
Legendary scientist James Watson files court brief against lunacy of gene patents
Public domain is not elementary, Sherlock
The Sherlock Holmes case highlights the stranglehold of copyright laws in the US
Spy versus spy and high tech gizmos
From secure manhole covers to Internet tracking systems, NSA has an arsenal of patents
How to save $25 billion and more on drug costs
Patent settlements bring cheaper generics to market early and cut healthcare spending
A patent triumph of public interest
New flexibilities make public interest safeguards integral to drug patent rights
Strong medicine for weak drug patents
Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend
Biodiversity—India’s other scandal
CAG slams the national biodiversity authority for allowing questionable patents
Left sees red over Marx copyright
A small publisher of Collected Works has run afoul of Marxists by asserting copyright
Bitter ABS medicine for AYUSH
Manufacturers cry foul as they receive notices from state boards to pay royalty